Merck KGaA and Pfizer have joined BioXcel and Nektar Therapeutics' clinical collaboration to test Bavencio in combination with two other cancer therapies as a treatment for pancreatic cancer.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.